It includes a Venous Access Monitor (VAM) to reduce the risk of external blood loss and a Wetness Detector for added security.
Studies on online HDF delivered via systems like the 6008 have shown promising results. The CONVINCE study (2022) demonstrated that high-volume HDF reduces all-cause mortality by 23% compared to standard hemodialysis. Additionally, patients on the 6008 often report fewer post-dialysis symptoms (fatigue, headache, nausea), improved blood pressure control, and reduced need for phosphate binders due to better middle-molecule clearance. 6008 dialysis machine
The 6008 dialysis machine is not merely an incremental update; it is a comprehensive therapeutic system that aligns with the goals of modern nephrology: improving survival, reducing morbidity, and enhancing quality of life. By automating critical safety checks, enabling high-volume HDF, and reducing staff burden, it sets a new benchmark for dialysis delivery. However, its full benefits can only be realized in settings with robust water treatment and trained personnel. For patients and providers alike, the 6008 represents a move away from “survival on dialysis” toward “thriving on dialysis”—a goal that should guide the future of renal replacement therapy. It includes a Venous Access Monitor (VAM) to